First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
26 hedge funds and large institutions have $11.9M invested in First Trust Nasdaq Pharmaceuticals ETF in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.31M | |
| 2 | +$1.3M | |
| 3 | +$499K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$354K |
| 5 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$304K |
Top Sellers
| 1 | -$588K | |
| 2 | -$306K | |
| 3 | -$145K | |
| 4 |
SC
Steph & Co
Marinette,
Wisconsin
|
-$142K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$13.3K |
